Diabetics who use Novorapid-type insulin report unbalanced glucose values. Novo Nordisk said: "Ineffectiveness can be due to a number of factors" Ministry of Health: "At this stage, no evidence of a problem with the quality of the preparation has been found" The preparation in question is a pen-like syringe for self-injection of insulin intended for adults, adolescents and children.
The firm checked with the firm with the company and at this stage there was no evidence that there was a problem.